Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors

C. X. Ma, M. J. Ellis

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors'. Together they form a unique fingerprint.